ADMA Biologics Files 8-K Report
Ticker: ADMA · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1368514
| Field | Detail |
|---|---|
| Company | Adma Biologics, Inc. (ADMA) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, financials
Related Tickers: ADMA
TL;DR
ADMA Biologics filed an 8-K on 4/28/25, mostly routine stuff.
AI Summary
On April 28, 2025, ADMA Biologics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided excerpt. The company, incorporated in Delaware, operates in the biological products sector.
Why It Matters
This 8-K filing indicates routine corporate reporting, potentially including updates on financial statements or other operational disclosures for ADMA Biologics, Inc.
Risk Assessment
Risk Level: low — The filing appears to be a routine 8-K with no immediate indication of significant negative or positive events.
Key Players & Entities
- ADMA BIOLOGICS, INC. (company) — Registrant
- April 28, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-36728 (filing_id) — SEC File Number
- 56-2590442 (tax_id) — IRS Employer Identification No.
- 465 State Route 17, Ramsey, New Jersey 07446 (address) — Principal Executive Offices
- (201) 478-5552 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for ADMA Biologics, Inc. on April 28, 2025?
The filing is for 'Other Events' and 'Financial Statements and Exhibits', indicating routine corporate reporting rather than a specific material event.
In which state is ADMA Biologics, Inc. incorporated?
ADMA Biologics, Inc. is incorporated in Delaware.
What is the principal executive office address for ADMA Biologics, Inc.?
The principal executive office is located at 465 State Route 17, Ramsey, New Jersey 07446.
What is the SEC file number for ADMA Biologics, Inc.?
The SEC file number is 001-36728.
Does this filing indicate any specific new product launches or regulatory approvals for ADMA Biologics, Inc.?
The provided excerpt does not detail specific new product launches or regulatory approvals; it categorizes the filing under 'Other Events' and 'Financial Statements and Exhibits'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding ADMA BIOLOGICS, INC. (ADMA).